MUFG Securities EMEA’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$740K Hold
2,951
0.01% 446
2025
Q4
$812K Buy
2,951
+1,575
+114% +$431K 0.01% 445
2025
Q3
$361K Buy
1,376
+1,163
+546% +$283K 0.01% 424
2025
Q2
$46.6K Buy
+213
New +$45.5K ﹤0.01% 455
2020
Q2
Sell
-28,800
Closed -$4.38M 516
2020
Q1
$4.38M Buy
+28,800
New +$4.43M 0.04% 207
2019
Q2
Sell
-88,700
Closed -$9.78M 545
2019
Q1
$9.78M Buy
+88,700
New +$9.23M 0.11% 143

Other funds holding WST

MUFG Securities EMEA's WST Position: Q1 2026 in Review

MUFG Securities EMEA held its West Pharmaceutical (WST) position steady in Q1 2026 at 2,951 shares worth $740K. The position accounts for 0.01% of the portfolio, ranked #446.

MUFG Securities EMEA first reported a position in WST in Q1 2019 and has held it in 6 quarters since. The position peaked at $9.78M in Q1 2019. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • MUFG Securities EMEA held 2,951 shares of West Pharmaceutical worth $740K as of Q1 2026.
  • MUFG Securities EMEA left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up 0.01% of MUFG Securities EMEA's portfolio in Q1 2026, its #446 holding.
  • MUFG Securities EMEA first reported a position in West Pharmaceutical in Q1 2019 and has held it in 6 quarters since.
  • MUFG Securities EMEA's West Pharmaceutical position peaked at $9.78M in Q1 2019.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.